Navigation Links
Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at AASLD 2008
Date:11/3/2008

ffects an estimated 4.1 million Americans.

About Romark Laboratories

Romark Laboratories (http://www.romark.com), a privately held biopharmaceutical company, has discovered and developed a new class of small molecule antivirals known as thiazolides. The Company is developing nitazoxanide, the first of the thiazolide class, for the treatment of chronic hepatitis C, and is developing other new thiazolides for treating viral diseases including chronic hepatitis B. Alinia(R) (nitazoxanide) is approved by the U.S. Food and Drug Administration and marketed by Romark for the treatment of Cryptosporidium and Giardia infection.


'/>"/>
SOURCE Romark Laboratories
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
2. Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
3. Romark Laboratories Announces Presentation of New Nitazoxanide Data at 59th Annual AASLD Meeting and 50th Anniversary IASL Meeting in San Francisco
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ENHEIM,Ontario,Nov.24/PRNewswire-FirstCall/--DowAg...tsofHylandSeeds,adivisionofThompsonsLimitedofBlenh...andDowAgroSciences,currentseedsbusinessasthecompan...10 andDowAgroSciencesHerbicideTolerantTraitTechno...thenearfuture. ,, "Thisacquisitionbringstogethe...
(Date:11/24/2009)...eland,November24/PRNewswire-FirstCall/--deCODE,gen...ofallofits,"firstday"motionsbytheU.S.BankruptcyCou...deCODElastweekfiledavoluntarypetitionfor,reliefund...BankruptcyCourt. , TheordersissuedbytheBankru...inessduringtheChapter11proceedings.Inparticular,th...
(Date:11/24/2009)...24/PRNewswire/--BlueMarbleEnergyCorp.announcedtoda...ity(OPDA)wererecentlyawarded$2millionbyWashingtonS...aprivate/publicpartnershiptoconstructthestate,sfir...A. ,, "Thisinvestmentwillsignificantlyspeedthed...oLincolnCounty,"saidBlueMarbleEnergyCEOKellyOgilvi...
(Date:11/24/2009)...ber24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,NAS...mpany,today,announcedthatithassubmittedaMAAtotheEu...any,senzymereplacementtherapyindevelopment,forthet...ing,applicationforvelaglucerasealfathathasbeensubm...Canada. , Basedonaglobalsupplyshortageofthecu...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...pt. 22, 2008 -- Chemists at Rice University have d...d nanorods -- tiny, wand-like nanoparticles that a...pplications as broad as diagnosing disease and imp...high-aspect-ratio gold nanorods produced by today,..." said lead researcher Eugene Zubarev, assistant p...
...Fla. and WILMINGTON, Del., Sept. 22 For,his lifet...nd the risks of,radiation and other environmental ...ership in pediatric clinical care, research and ed... as the recipient of the prestigious 2008,Alfred I... Care by Nemours,one of the nation,s largest child...
...Sept. 22 /PRNewswire/ - ACAMP Alberta Centre for A...ucts is pleased to announce the,appointment of Dr.... new,role Dr. Yallup will lead the product develop...pability in Alberta for the packaging and assembly...ing them into market-ready,commercial or industria...
Other Biology Technology:Purifying nanorods: Big success with tiny cleanup 2Robert L. Brent, MD, PhD, Honored with 2008 Alfred I. duPont Award for Excellence in Children's Health Care 2Chief Technology Officer Joins ACAMP 2
(Date:11/24/2009)... For thousands of years it has been prescribed by ...ailments from headaches and stomach pain to fever ... Newcastle University have been able to scientific...s crenata otherwise known as Brazilian mint. , ...the team led by researcher Graciela Rocha was able...
(Date:11/24/2009)... Rocket science is opening new doors to understand...fect the hearing of a marine mammal or if they he...l sized X-ray scanners that NASA uses to detect fl...kets is now allowing scientists to peek inside the...tailed three-dimensional replicas of a whale,s hea...
(Date:11/24/2009)... Stents that keep weakened and flabby arteries fro... six months, those stents are no longer needed -- ...necessary. Previously, doctors had no choice but t...of Tel Aviv University,s Department of Biomedical ...er platform that carries drugs where they,re neede...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2A coating for life 2Author Alison Stein Identifies Widespread Crisis in Personal Responsibility Outlines Path to Solution in Reality 54180 1Author Alison Stein Identifies Widespread Crisis in Personal Responsibility Outlines Path to Solution in Reality 54180 2Jennerex Closes 245 Million First Tranche of Series C Financing 13499 1Jennerex Closes 245 Million First Tranche of Series C Financing 13499 2ETHICON Introduces New Product Enhancement and Packaging for BIOPATCH 28R 29 to Improve Ease of Application for Patients with Catheters 54177 1ETHICON Introduces New Product Enhancement and Packaging for BIOPATCH 28R 29 to Improve Ease of Application for Patients with Catheters 54177 2
...s Hopkins undergraduates have invented a device to...horing transplanted insulin-producing cells inside...nd two freshmen, working with Johns Hopkins doctor... should fit inside the portal vein, which feeds in...of therapeutic cells in one place, allowing them t...
... since the relationship between land area and numb...er function, islands and island archipelagoes have...species from large continents arrive and, over tim.... , Since islands have many times fewer species t...tinents were rich sources from which islands drew ...
...human and chimpanzee genomes vary by just 1.2 perc... mental and linguistic capabilities between the tw...of neuropsin, a protein that plays a role in learn...ervous systems of humans and that it originated le... demonstrated the molecular mechanism that creates...
Other Biology News:Students invent protective pouch to enhance cell therapy 2Students invent protective pouch to enhance cell therapy 3Students invent protective pouch to enhance cell therapy 4Invasion of the island bats 2Gene mutation linked to cognition is found only in humans 2
Creatinine Colorimetric Assay Kit, QuantiChrom from BioAssay Systems
...CL Plus Western Blotting Reagent Pack, 1. Contain...ection of membrane-bound mouse and rabbit primary ...r PVDF membranes. Detection reagents are not inclu...Plus. Category: Blotting & Labeling & Detection, ...
BBS/Glycerol/Casein Block and Diluent - 10X Concentrate from BioFX Laboratories, Inc.
Mouse Anti-Cyclophilin D Monoclonal Antibody, Unconjugated, Clone PADZC006 from Invitrogen
Biology Products: